[Medical Reimbursement] FY2026 Revision, Interpretation of Doubts (Part 1) Released – PT-OT

This timeRelease of "Interpretation of Doubts (Part 1)"The release of the "Interpretation of Doubts (Part 1)" marks a crucial juncture where the abstract policies of the medical reimbursement revision are elevated to "absolute rules" directly impacting on-site revenue. Specifically, the detailed presentation of calculation requirements in the rehabilitation field involving PT, OT, and ST will necessitate a re-evaluation of the validity of previously maintained additional fees and facility standards.

In the context of medical M&A and business succession, this interpretation of doubts becomesa variable influencing the accuracy of due diligence. For medical institutions considering divestiture, revenue simulations based on the latest interpretations are essential. Failure to meet standards could lead to a significant reduction in goodwill value. Conversely, establishing a system to meet standards early can dramatically increase market scarcity.

As a takeaway for executives and successors, these subtle changes in regulations should not be dismissed as mere "administrative confirmations." Instead, they should be viewed asan opportunity for re-evaluating the financial strength of one's own institution. If maintaining facility standards independently becomes difficult due to stricter requirements, considering resource consolidation through group affiliation before the revision's impact is fully reflected in financial statements is a strategic decision that maximizes business value.